BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 36645194)

  • 21. Germline and Somatic Tumor Testing in Epithelial Ovarian Cancer: ASCO Guideline.
    Konstantinopoulos PA; Norquist B; Lacchetti C; Armstrong D; Grisham RN; Goodfellow PJ; Kohn EC; Levine DA; Liu JF; Lu KH; Sparacio D; Annunziata CM
    J Clin Oncol; 2020 Apr; 38(11):1222-1245. PubMed ID: 31986064
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Family history of breast and ovarian cancers and BRCA1 and BRCA2 mutations in a population-based series of early-onset breast cancer.
    Loman N; Johannsson O; Kristoffersson U; Olsson H; Borg A
    J Natl Cancer Inst; 2001 Aug; 93(16):1215-23. PubMed ID: 11504767
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical management of women with genomic BRCA1 and BRCA2 mutations.
    Chang J; Elledge RM
    Breast Cancer Res Treat; 2001 Sep; 69(2):101-13. PubMed ID: 11759816
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk factors and prognostic factors in patients with double primary cancer: epithelial ovarian cancer and breast cancer.
    Cvelbar M; Ursic-Vrscaj M; Rakar S
    Eur J Gynaecol Oncol; 2005; 26(1):59-63. PubMed ID: 15755003
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Statewide Retrospective Review of Familial Pancreatic Cancer in Delaware, and Frequency of Genetic Mutations in Pancreatic Cancer Kindreds.
    Catts ZA; Baig MK; Milewski B; Keywan C; Guarino M; Petrelli N
    Ann Surg Oncol; 2016 May; 23(5):1729-35. PubMed ID: 26727920
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ovarian cancer risk of Chinese women with BRCA1/2 germline pathogenic variants.
    Yao L; Sun J; Hu L; Chen J; Zhang J; Xu Y; Xie Y
    J Hum Genet; 2022 Nov; 67(11):639-642. PubMed ID: 35864222
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The first Japanese nationwide multicenter study of
    Enomoto T; Aoki D; Hattori K; Jinushi M; Kigawa J; Takeshima N; Tsuda H; Watanabe Y; Yoshihara K; Sugiyama T
    Int J Gynecol Cancer; 2019 Jul; 29(6):1043-1049. PubMed ID: 31263023
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cancer Incidence in First- and Second-Degree Relatives of BRCA1 and BRCA2 Mutation Carriers.
    Streff H; Profato J; Ye Y; Nebgen D; Peterson SK; Singletary C; Arun BK; Litton JK
    Oncologist; 2016 Jul; 21(7):869-74. PubMed ID: 27306910
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between the cervicovaginal microbiome, BRCA1 mutation status, and risk of ovarian cancer: a case-control study.
    Nené NR; Reisel D; Leimbach A; Franchi D; Jones A; Evans I; Knapp S; Ryan A; Ghazali S; Timms JF; Paprotka T; Bjørge L; Zikan M; Cibula D; Colombo N; Widschwendter M
    Lancet Oncol; 2019 Aug; 20(8):1171-1182. PubMed ID: 31300207
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Progression-free survival and overall survival after BRCA1/2-associated epithelial ovarian cancer: A matched cohort study.
    Heemskerk-Gerritsen BAM; Hollestelle A; van Asperen CJ; van den Beek I; van Driel WJ; van Engelen K; Gómez Garcia EB; de Hullu JA; Koudijs MJ; Mourits MJE; Hooning MJ; Boere IA
    PLoS One; 2022; 17(9):e0275015. PubMed ID: 36137114
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Weight Gain and the Risk of Ovarian Cancer in
    Kim SJ; Lubinski J; Huzarski T; Møller P; Armel S; Karlan BY; Senter L; Eisen A; Foulkes WD; Singer CF; Tung N; Bordeleau L; Neuhausen SL; Olopade OI; Eng C; Weitzel JN; Fruscio R; Narod SA; Kotsopoulos J;
    Cancer Epidemiol Biomarkers Prev; 2021 Nov; 30(11):2038-2043. PubMed ID: 34426412
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic, clinic and histopathologic characterization of BRCA-associated hereditary breast and ovarian cancer in southwestern Finland.
    Pallonen TA; Lempiäinen SMM; Joutsiniemi TK; Aaltonen RI; Pohjola PE; Kankuri-Tammilehto MK
    Sci Rep; 2022 Apr; 12(1):6704. PubMed ID: 35469032
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Familial risks, early-onset breast cancer, and BRCA1 and BRCA2 germline mutations.
    Dite GS; Jenkins MA; Southey MC; Hocking JS; Giles GG; McCredie MR; Venter DJ; Hopper JL
    J Natl Cancer Inst; 2003 Mar; 95(6):448-57. PubMed ID: 12644538
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation.
    Finch A; Beiner M; Lubinski J; Lynch HT; Moller P; Rosen B; Murphy J; Ghadirian P; Friedman E; Foulkes WD; Kim-Sing C; Wagner T; Tung N; Couch F; Stoppa-Lyonnet D; Ainsworth P; Daly M; Pasini B; Gershoni-Baruch R; Eng C; Olopade OI; McLennan J; Karlan B; Weitzel J; Sun P; Narod SA;
    JAMA; 2006 Jul; 296(2):185-92. PubMed ID: 16835424
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk of cancer at sites other than the breast in Swedish families eligible for BRCA1 or BRCA2 mutation testing.
    Lorenzo Bermejo J; Hemminki K
    Ann Oncol; 2004 Dec; 15(12):1834-41. PubMed ID: 15550590
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Germline variants profiling of BRCA1 and BRCA2 in Chinese Hakka breast and ovarian cancer patients.
    Zhang Y; Wu H; Yu Z; Li L; Zhang J; Liang X; Huang Q
    BMC Cancer; 2022 Aug; 22(1):842. PubMed ID: 35918668
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Breast Cancer Survival of BRCA1/BRCA2 Mutation Carriers in a Hospital-Based Cohort of Young Women.
    Schmidt MK; van den Broek AJ; Tollenaar RA; Smit VT; Westenend PJ; Brinkhuis M; Oosterhuis WJ; Wesseling J; Janssen-Heijnen ML; Jobsen JJ; Jager A; Voogd AC; van Leeuwen FE; van 't Veer LJ
    J Natl Cancer Inst; 2017 Aug; 109(8):. PubMed ID: 28376189
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Family history of breast and ovarian cancer and the risk of breast carcinoma in situ.
    Claus EB; Stowe M; Carter D
    Breast Cancer Res Treat; 2003 Mar; 78(1):7-15. PubMed ID: 12611452
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Penetrance of breast cancer, ovarian cancer and contralateral breast cancer in BRCA1 and BRCA2 families: high cancer incidence at older age.
    van der Kolk DM; de Bock GH; Leegte BK; Schaapveld M; Mourits MJ; de Vries J; van der Hout AH; Oosterwijk JC
    Breast Cancer Res Treat; 2010 Dec; 124(3):643-51. PubMed ID: 20204502
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk of prostate, ovarian, and endometrial cancer among relatives of women with breast cancer.
    Tulinius H; Egilsson V; Olafsdóttir GH; Sigvaldason H
    BMJ; 1992 Oct; 305(6858):855-7. PubMed ID: 1422397
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.